Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy

Fig. 3

Kaplan-Meier survival curves for patients with advanced oesophageal cancer in different LMR groups. The blue curve represents the overall survival of patients with an LMR less than 3.03, while the green curve represents the overall survival of patients with an LMR greater than or equal to 3.03. The mean survival time of patients in the group with an LMR less than 3.03 was 8.3 months, while that of patients in the group with an LMR greater than or equal to 3.03 was 20.2 months, with a p value less than 0.05, indicating a significant difference between the two groups

Back to article page
\